Genesis Tech Transfer Boost (GTTB), an investment vehicle created in 2022 and managed by the consulting firm GENESIS Biomed has made its third investment for a ticket of €50,000 in the biotech company Affirma Biotech, both members of CataloniaBio & HealthTech.
Affirma Biotech are multiple infectious diseases that can benefit from treatment through immune system activation, these compounds can be used across a broad spectrum of indications. The first two, that the company is considering developing, are treatments for severe influenza and chronic hepatitis B. In the case of influenza, despite vaccination campaigns, the WHO estimates that annual deaths reach 650,000 patients. Chronic hepatitis B affects around 300 million patients worldwide and is the leading cause of liver cancer, killing up to 1 million people a year.
This GENESIS Tech Transfer Boost ticket, that is part of the closing of an investment round, is joined by other funding sources such as NEOTEC, a CDTI programme, and a public-private partnership project, representing a total of €1.75 million in funding to advance the development of its new broad-spectrum anti-infectives.
The closing of the investment round was led by Nara Capital and the company's current partners, in particular BCN Peptides, Reig Jofre Investments and Alfons Hidalgo, with the participation of the GTTB vehicle, managed by GENESIS Biomed, and private investors through the Capital Cell platforms and its international partner Seedblink.
According to Josep Lluís Falcó, director of GENESIS Tech Transfer Boost and co-founder and CEO of GENESIS Biomed, "Affirma represents a great bet for our portfolio of investee companies, developing new drugs to stimulate the immune system in the treatment of viral and bacterial infections. The participation of Nara Capital and relevant investors from the pharmaceutical sector highlights the potential of immunotherapy extending from oncology to other areas, such as infectious diseases. We are confident that a promising future lies ahead in this field".
Comments